MedPath

贵州百灵企业集团制药股份有限公司

贵州百灵企业集团制药股份有限公司 logo
🇨🇳China
Ownership
Public
Established
1999-03-25
Employees
5.7K
Market Cap
-
Website
http://www.gzbl.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

139

NMPA:139

Drug Approvals

经带宁胶囊

Approval Number
国药准字Z20025009
Approval Date
Sep 19, 2024
NMPA

牛黄解毒片

Approval Number
国药准字Z52020124
Approval Date
Sep 19, 2024
NMPA

咳速停胶囊

Approval Number
国药准字Z20025237
Approval Date
Sep 19, 2024
NMPA

风热感冒颗粒

Approval Number
国药准字Z52020190
Approval Date
Sep 19, 2024
NMPA

风寒感冒颗粒

Approval Number
国药准字Z52020189
Approval Date
Sep 19, 2024
NMPA

复方一枝黄花喷雾剂

Approval Number
国药准字Z20025898
Approval Date
Sep 6, 2024
NMPA

咳速停糖浆

Approval Number
国药准字Z20025238
Approval Date
Sep 6, 2024
NMPA

银丹心脑通软胶囊

Approval Number
国药准字Z20027144
Approval Date
Aug 27, 2024
NMPA

炎立消丸

Approval Number
国药准字Z20090538
Approval Date
Aug 21, 2024
NMPA

除脂生发片

Approval Number
国药准字Z20093388
Approval Date
Aug 21, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 14
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.